Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

BioNTech SE (22UAy)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
82.90 -0.05    -0.06%
23/04 - Closed. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  US09075V1026 
S/N:  A2PSR2
  • Volume: 524
  • Bid/Ask: 82.00 / 83.65
  • Day's Range: 81.50 - 83.60
BioNTech 82.90 -0.05 -0.06%

22UAy Ratios

 
Assess the performance of BioNTech (BNTX). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on BioNTech SE's latest financial reports. Compare the performance metrics of BioNTech (BNTX) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 21.4 8.69
Price to Sales TTM 5.21 924.91
Price to Cash Flow MRQ 3.71 12.06
Price to Free Cash Flow TTM 3.89 10.41
Price to Book MRQ 0.98 2.91
Price to Tangible Book MRQ 1.04 4.32
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 84.29% -103.52
Gross Margin 5YA 85.36% -979.45
Operating margin TTM 25.39% -2,257.71
Operating margin 5YA -14.49% -3,283.32
Pretax margin TTM 31.06% -12,041.01
Pretax margin 5YA -10.35% -8,727.79
Net Profit margin TTM 24.36% -12,047.11
Net Profit margin 5YA -20.07% -11,227.35
   
Revenue/Share TTM 16.07 43.47
Basic EPS ANN 3.87 16.01
Diluted EPS ANN 3.83 15.32
Book Value/Share MRQ 85.17 85.32
Tangible Book Value/Share MRQ 80.35 83.7
Cash/Share MRQ 49.07 24.11
Cash Flow/Share TTM 22.6 14.57
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 4.62% -11.36
Return on Equity 5YA 32.92% 8.92
Return on Assets TTM 4.02% 2.71
Return on Assets 5YA 37.64% 10.71
Return on Investment TTM 3.81% 5.25
Return on Investment 5YA 49.58% 13.75
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ -79.64% -39.75
EPS(TTM) vs TTM 1 Yr. Ago TTM -90.03% -109.35
5 Year EPS Growth 5YA 0% 8.92
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ -65.43% 33.38
Sales (TTM) vs TTM 1 Yr. Ago TTM -77.94% 31.87
5 Year Sales Growth 5YA 97.35% 46.77
5 Year Capital Spending Growth 5YA 52.93% 14.35
   
Quick Ratio MRQ 9.04 3.95
Current Ratio MRQ 9.43 4.62
LT Debt to Equity MRQ 0.01% 9.67
Total Debt to Equity MRQ 1.08% 1.69
Efficiency    
Asset Turnover TTM 0.17 0.35
Inventory Turnover TTM 1.5 4.8
Revenue/Employee TTM 622.70K 749.61K
Net Income/Employee TTM 151.69K -279.13K
Receivable Turnover TTM 2.84 5.82
   
Dividend Yield ANN - 0.06
Dividend Yield 5 Year Avg. 5YA - 0.05
Dividend Growth Rate ANN 0% 0.12
Payout Ratio TTM - 3.21
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BNTX Comments

Write your thoughts about Biontech SE
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Besim Ersan
Besim Ersan Apr 11, 2024 2:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Any news from anti-cancer works?..
Reply
0 0
Report
Jeromy Pow
Jeromy Pow Sep 29, 2023 1:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hope BNTX will bring their anti-cancer pipeline of the future forward so this will go to moon again and beyond! I especially love the fact that they are developing something against lung cancer!
Reply
5 4
Report
TheGlobe Trade
TheGlobe Trade Jun 27, 2023 3:31AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
300% Gain from here Gauranteed
Reply
5 4
Report
TheGlobe Trade
TheGlobe Trade Apr 27, 2023 9:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Thank you MM
Reply
1 2
Report
TheGlobe Trade
TheGlobe Trade Apr 24, 2023 7:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Strong Buy. This is a steal!
Reply
2 3
Report
Donavan Allen
Donavan Allen Mar 27, 2023 7:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
How about those earnings?! 👀
Reply
1 0
Report
Carlos GV
Carlos GV Feb 24, 2023 9:46AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
sold this trash... bye bye
Reply
3 3
Report
Jay Ow
Jay Ow Dec 07, 2022 6:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
who want buy this can you tell me. So many court is coming. They will must pay a lot for deaths. Full twitter so whole world know
Reply
2 15
Report
Alper Drn
Alper Drn Dec 07, 2022 6:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Will buy more..
Reply
8 1
Report
cc cc
cc cc Dec 07, 2022 6:53PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
They cant be sued. They had all emergency approval, meaning all goverments waived the right to sue. That was a free lunch for these companies...you have to sue the governments
Reply
1 0
Report
Ying Yu
Ying Yu Nov 10, 2022 4:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The mRNA vaccine looks like a joke in the vaccine history. It couldn't stop COVID infection and spreading. Biden, Fauci, the head of CDC and The CEO of Pfizer were infected COVID virus after they got 4 shots of mRNA vaccine. Does mRNA vaccine can generate enough folded spike protein as antigen for Antigen presenting cells? Who knows? mRNA vaccine looks like generating shot term nonspecific immune response by its longer RNA chain.
Reply
2 22
Report
murat ribar
murat ribar Nov 10, 2022 4:58AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
You mean China is a big performer. Funny.
Reply
1 0
Report
Jack Black
Jack Black Sep 14, 2022 5:03PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Anyone can recommend me some books to improve my operations? In particular on how to manage my capital. Thank you
Reply
3 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email